Can B Past Earnings Performance

Past criteria checks 0/6

Can B's earnings have been declining at an average annual rate of -18.5%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 13.1% per year.

Key information

-18.5%

Earnings growth rate

60.1%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate13.1%
Return on equityn/a
Net Margin-985.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Can B makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CANB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-1440
31 Mar 242-1440
31 Dec 232-1050
30 Sep 232-1140
30 Jun 235-14100
31 Mar 236-13110
31 Dec 227-15130
30 Sep 228-16150
30 Jun 227-12110
31 Mar 226-13110
31 Dec 215-12100
30 Sep 213-13140
30 Jun 212-11110
31 Mar 211-1090
31 Dec 202-990
30 Sep 202-670
30 Jun 202-670
31 Mar 202-670
31 Dec 192-660
30 Sep 192-350
30 Jun 192-650
31 Mar 191-640
31 Dec 181-430
30 Sep 180-620
30 Jun 180-220
31 Mar 180-210
31 Dec 170-210
30 Sep 170-100
30 Jun 170-100
31 Mar 170000
31 Dec 160-100
30 Sep 160-100
30 Jun 160-110
31 Mar 160-110
31 Dec 150-420
30 Sep 150-310
31 Dec 140000
31 Dec 130000

Quality Earnings: CANB is currently unprofitable.

Growing Profit Margin: CANB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CANB is unprofitable, and losses have increased over the past 5 years at a rate of 18.5% per year.

Accelerating Growth: Unable to compare CANB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CANB is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).


Return on Equity

High ROE: CANB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies